A new publication involving acetyl hexapeptide-8 was published on October 1, 2026. The study, titled "The effect of a serum containing acetyl hexapeptide-8, dipeptide diaminobutyroyl benzylamide diacetate and gluconolactone on skin biomarkers, wrinkles and skin texture: Ex vivo and clinical studies," appeared in the International Journal of Cosmetic Science.
The publication examines a serum formulation that includes acetyl hexapeptide-8 alongside dipeptide diaminobutyroyl benzylamide diacetate and gluconolactone. According to the title, the research covers both ex vivo and clinical study components related to skin biomarkers, wrinkles, and skin texture.
No specific findings, results, or conclusions from the study are detailed here beyond the scope described in the publication title. This brief reports only the existence and bibliographic details of the publication as listed in the source record, identified under PubMed ID 41668671.
Readers interested in the broader context of this compound, including its regulatory status and prior research, can consult the compound overview for additional background.